Relationship Between Chlamydia Pneumoniae and Abdominal Aortic Aneurysm_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

SHI Sen , HE Yanzheng , LIU Yong , SONG Li.

Department of Vascular Surgery, The First Affiliated Hospital of Luzhou Medical College, Luzhou 646000, China;

Corresponding author：

Keywords：

Chlamydia pneumoniae; Abdominal aortic aneurysm; Matrix metalloproteinase; Apoptosis

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective　To investigate the recent studies about the relationship between Chlamydia pneumoniae and abdominal aortic aneurysm. Methods　The current literatures about the relationship between Chlamydia pneumoniae and abdominal aortic aneurysm were reviewed. Results　Chlamydia pneumoniae is one of the most important factors for the formation of abdominal aortic aneurysm since Chlamydia pneumoniae can cause abdominal aortic aneurysm through the metabolism of matrix metalloproteinases, the apoptosis of smooth muscle cells in the vessels and the chronic infection of the wall of the aneurysm. Conclusion　There maybe a distinguishingly close relationship between Chlamydia pneumoniae and abdominal aortic aneurysm, and Chlamydia pneumoiae may take an important role in the development and progress of the abdominal aortic aneurysm.

Citation： SHI Sen,HE Yanzheng,LIU Yong,SONG Li.. Relationship Between Chlamydia Pneumoniae and Abdominal Aortic Aneurysm. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2006, 13(6): 668-670. doi: Copy

1.	Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR [J]. J Infect Dis, 1990; 161(4)∶618.
2.	Robman L, Mahdi O, McCarty C, et al. Exposure to Chla-mydia pneumoniae infection and progression of age-related macular degeneration [J]. Am J Epidemiol, 2005; 161(11)∶1013.
3.	Koyi H, Branden E, Gnarpe J, et al. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study [J]. APMIS, 2001; 109(9)∶572.
4.	Stuart ES, Webley WC, Norkin LC. Lipid rafts, caveolae, ca-veolin-1, and entry by Chlamydiae into host cells [J]. Exp Cell Res, 2003; 287(1)∶67.
5.	Lindholt JS, Ashton HA, Scott RA. Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms [J]. J Vasc Surg, 2001; 34(2)∶212.
6.	Wolski A, Korobowicz E, Siezieniewska Z, et al. Immunofluorescence in situ and the serologic indices of Chlamydia pneumoniae infection in patients with an abdominal aortic aneurysm [J]. Pol J Pathol, 2002; 53(4)∶223.
7.	Wolski A, Mazur E, Niedzwiadek J, et al. The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm [J]. Pol Merkuriusz Lek, 2001; 11(66)∶491.
8.	Lindholt JS, Jorgensen B, Shi GP, et al. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms [J]. Eur J Vasc Endovasc Surg, 2003; 25(6)∶546.
9.	Mosorin M, Juvonen J, Biancari F, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study [J]. J Vasc Surg, 2001; 34(4)∶606.
10.	Tambiah J, Powell JT. Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: prevention with azithromycin [J]. J Vasc Surg, 2002; 36(5)∶1011.
11.	Wassef M, Baxter BT, Chisholm RL, et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute [J]. J Vasc Surg, 2001; 34(4)∶730.
12.	Tung WS, Lee JK, Thompson RW. Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array [J]. J Vasc Surg, 2001; 34(1)∶143.
13.	Rodel J, Prochnau D, Prager K, et al. Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae [J]. FEMS Immunol Med Microbiol, 2003; 38(2)∶159.
14.	Airenne S, Surcel HM, Tuukkanen J, et al. Chlamydia pneumoniae inhibits apoptosis in human epithelial and monocyte cell lines [J]. Scand J Immunol, 2002; 55(4)∶390.
15.	Ezzahiri R, Stassen FR, Kurvers HA, et al. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice [J]. Eur J Vasc Endovasc Surg, 2003; 26(1)∶88.
16.	袁中华，杨永宗，杨小毅，等. 氧化型低密度脂蛋白诱导猪主动脉平滑肌细胞凋亡 [J]. 中国动脉硬化杂志， 2002； 10(1)∶23.
17.	李　涛，许香广，张国良，等. 健康人群肺炎衣原体感染状况分析 [J]. 中国医学检验杂志， 2003； 2（4）∶66.
18.	Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells [J]. Infect Immun, 1996; 64(5)∶1614.
19.	Kowalewski R, Sobolewski K, Malkowski A, et al. Evaluation of enzymes involved in proteoglycan degradation in the wall of abdominal aortic aneurysms [J]. J Vasc Res, 2006; 43(1)∶95.
20.	Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages [J]. Arterioscler Thromb Vasc Biol, 2003; 23(5)∶769.
21.	Kim MP, Gaydos CA, Wood BJ, et al. Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism [J]. Infect Immun, 2005; 73(1)∶632.
22.	Porqueddu M, Spirito R, Parolari A, et al. Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall [J]. Circulation, 2002; 106(21)∶2647.

1. 　Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR [J]. J Infect Dis, 1990; 161(4)∶618.
2. 　Robman L, Mahdi O, McCarty C, et al. Exposure to Chla-mydia pneumoniae infection and progression of age-related macular degeneration [J]. Am J Epidemiol, 2005; 161(11)∶1013.
3. 　Koyi H, Branden E, Gnarpe J, et al. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study [J]. APMIS, 2001; 109(9)∶572.
4. 　Stuart ES, Webley WC, Norkin LC. Lipid rafts, caveolae, ca-veolin-1, and entry by Chlamydiae into host cells [J]. Exp Cell Res, 2003; 287(1)∶67.
5. 　Lindholt JS, Ashton HA, Scott RA. Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms [J]. J Vasc Surg, 2001; 34(2)∶212.
6. 　Wolski A, Korobowicz E, Siezieniewska Z, et al. Immunofluorescence in situ and the serologic indices of Chlamydia pneumoniae infection in patients with an abdominal aortic aneurysm [J]. Pol J Pathol, 2002; 53(4)∶223.
7. 　Wolski A, Mazur E, Niedzwiadek J, et al. The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm [J]. Pol Merkuriusz Lek, 2001; 11(66)∶491.
8. 　Lindholt JS, Jorgensen B, Shi GP, et al. Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms [J]. Eur J Vasc Endovasc Surg, 2003; 25(6)∶546.
9. 　 Mosorin M, Juvonen J, Biancari F, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study [J]. J Vasc Surg, 2001; 34(4)∶606.
10. 　Tambiah J, Powell JT. Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: prevention with azithromycin [J]. J Vasc Surg, 2002; 36(5)∶1011.
11. 　Wassef M, Baxter BT, Chisholm RL, et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute [J]. J Vasc Surg, 2001; 34(4)∶730.
12. 　Tung WS, Lee JK, Thompson RW. Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array [J]. J Vasc Surg, 2001; 34(1)∶143.
13. 　Rodel J, Prochnau D, Prager K, et al. Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae [J]. FEMS Immunol Med Microbiol, 2003; 38(2)∶159.
14. 　Airenne S, Surcel HM, Tuukkanen J, et al. Chlamydia pneumoniae inhibits apoptosis in human epithelial and monocyte cell lines [J]. Scand J Immunol, 2002; 55(4)∶390.
15. 　Ezzahiri R, Stassen FR, Kurvers HA, et al. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice [J]. Eur J Vasc Endovasc Surg, 2003; 26(1)∶88.
16. 　袁中华，杨永宗，杨小毅，等. 氧化型低密度脂蛋白诱导猪主动脉平滑肌细胞凋亡 [J]. 中国动脉硬化杂志， 2002； 10(1)∶23.
17. 　李　涛，许香广，张国良，等. 健康人群肺炎衣原体感染状况分析 [J]. 中国医学检验杂志， 2003； 2（4）∶66.
18. 　Gaydos CA, Summersgill JT, Sahney NN, et al. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells [J]. Infect Immun, 1996; 64(5)∶1614.
19. 　Kowalewski R, Sobolewski K, Malkowski A, et al. Evaluation of enzymes involved in proteoglycan degradation in the wall of abdominal aortic aneurysms [J]. J Vasc Res, 2006; 43(1)∶95.
20. 　Luan Z, Chase AJ, Newby AC. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages [J]. Arterioscler Thromb Vasc Biol, 2003; 23(5)∶769.
21. 　Kim MP, Gaydos CA, Wood BJ, et al. Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism [J]. Infect Immun, 2005; 73(1)∶632.
22. 　Porqueddu M, Spirito R, Parolari A, et al. Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall [J]. Circulation, 2002; 106(21)∶2647.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Relationship Between Chlamydia Pneumoniae and Abdominal Aortic Aneurysm

Abstract Full text Figures/Tables Video References Cited by

Format

Content